Health care stocks were mixed premarket Thursday, with the Health Care Select Sector SPDR Fund (XLV) down 0.1% and the iShares Biotechnology ETF (IBB) 0.4% higher.
AstraZeneca (AZN) stock was up more than 3% after the company posted higher Q3 core earnings and revenue.
Becton Dickinson (BDX) shares were down more than 6% after the company reported fiscal Q4 revenue that missed analysts' expectations.
Insulet (PODD) stock was up more than 4% after the company reported higher Q3 revenue and raised its 2025 revenue growth guidance.